Literature DB >> 19929430

Gender-related tumor necrosis factor-alpha responses in naïve volunteers with Toll-like receptor 4 polymorphisms exposed in a swine confinement facility.

Ambikaipakan Senthilselvan1, Liliane Chénard, Shelley Kirychuk, Bernardo Predicala, David A Schwartz, Lauranell H Burch, Donna C Rennie, Philip J Willson, James A Dosman.   

Abstract

The aim of this work is to better understand the responses of people that are exposed to agricultural organic dust and other factors in modern swine production. We investigated the effects of toll-like receptor 4 (TLR4) genotype and gender on respiratory responses of naïve volunteers (18-28 years) to swine barn exposure. Non-smoking healthy subjects (16 men and 13 women) with TLR4 299 (Asp299Gly) and/or 399 (Thr399Ile) polymorphisms (TLR4 299/399) and age-sex matched subjects with TLR4 wild-type alleles spent 5 h in a nonexposed environment (baseline day) and 5 h in a swine facility (exposure day). The results showed significant decreases between baseline and exposure days in across-shift forced vital capacity (FVC), forced expiratory volume in 1 second (FEV(1)), forced midexpiratory flow rate (FEF(25-75)), and FEV(1)/FVC ratio and in methacholine concentration that reduced FEV1 by 20% (PC(20)) in all groups; however, there were no differences by sex or genotype. Similarly, nasal cytokines, serum cytokines, and blood neutrophil count increased after exposure; in contrast, however, these were influenced by gender. The increase in serum tumor necrosis factor-alpha (TNF-alpha) between baseline and exposure was gender-dependent with male sex associated with a significant increase in the wild-type group and female sex associated with a significant increase in the polymorphic group. These results suggest that for persons exposed to a swine facility, one's immunological response varies with gender as well as TLR4 genotype.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19929430     DOI: 10.1089/jir.2009.0002

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  6 in total

1.  Amphiregulin modulates murine lung recovery and fibroblast function following exposure to agriculture organic dust.

Authors:  Jill A Poole; Tara M Nordgren; Art J Heires; Amy J Nelson; Dawn Katafiasz; Kristina L Bailey; Debra J Romberger
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-06       Impact factor: 5.464

2.  Gender-specific associations between polymorphisms in the Toll-like receptor (TLR) genes and lung function among workers in swine operations.

Authors:  Zhiwei Gao; James A Dosman; Donna C Rennie; David A Schwartz; Ivana V Yang; Jeremy Beach; Ambikaipakan Senthilselvan
Journal:  J Toxicol Environ Health A       Date:  2018-11-12

3.  Toll-like receptor gene polymorphisms are associated with susceptibility to Graves' ophthalmopathy in Taiwan males.

Authors:  Wen-Ling Liao; Rong-Hsing Chen; Hui-Ju Lin; Yu-Huei Liu; Wen-Chi Chen; Yuhsin Tsai; Lei Wan; Fuu-Jen Tsai
Journal:  BMC Med Genet       Date:  2010-11-05       Impact factor: 2.103

Review 4.  The Effect of Inhalant Organic Dust on Bone Health.

Authors:  Joseph M Carrington; Jill A Poole
Journal:  Curr Allergy Asthma Rep       Date:  2018-02-22       Impact factor: 4.806

5.  Sex-Specific Differences in Resolution of Airway Inflammation in Fat-1 Transgenic Mice Following Repetitive Agricultural Dust Exposure.

Authors:  Arzu Ulu; Jalene V Velazquez; Abigail Burr; Stefanie N Sveiven; Jun Yang; Carissa Bravo; Bruce D Hammock; Tara M Nordgren
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

6.  A high docosahexaenoic acid diet alters lung inflammation and recovery following repetitive exposure to aqueous organic dust extracts.

Authors:  Arzu Ulu; Abigail Burr; Art J Heires; Jacqueline Pavlik; Tricia Larsen; Pedro A Perez; Carissa Bravo; Nicholas V DiPatrizio; Michelle Baack; Debra J Romberger; Tara M Nordgren
Journal:  J Nutr Biochem       Date:  2021-06-12       Impact factor: 6.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.